Corcept Therapeutics (CORT) FCF Margin Growth (1y) (2013 - 2026)
Corcept Therapeutics (CORT) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,187.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Corcept Therapeutics | 9.56 Bn | 9.22 Bn | 162.02 Mn | -1,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,326.00 |
| Dec 31, 2025 | -1,396.00 |
| Sep 30, 2025 | -1,302.00 |
| Jun 30, 2025 | -214.00 |
| Mar 31, 2025 | -1,321.00 |
| Dec 31, 2024 | 2,887.00 |
| Sep 30, 2024 | -352.00 |
| Jun 30, 2024 | -1,094.00 |
| Mar 31, 2024 | -839.00 |
| Dec 31, 2023 | -2,828.00 |
| Sep 30, 2023 | 1,004.00 |
| Jun 30, 2023 | 1,840.00 |
| Mar 31, 2023 | -1,304.00 |
| Dec 31, 2022 | -1,758.00 |
| Sep 30, 2022 | -1,777.00 |
| Jun 30, 2022 | -3,085.00 |
| Mar 31, 2022 | 576.00 |
| Dec 31, 2021 | 955.00 |
| Sep 30, 2021 | 1,606.00 |
| Jun 30, 2021 | -1,172.00 |